Browsing “ Uncategorized”

EVERSANA Sponsors the 15th Annual Commercial Contract and Chargeback Excellence

EVERSANA is a sponsor at the 15th Annual Commercial Contract and Chargeback Excellence conference on June 25-26, 2019, taking place in Philadelphia, PA. Join Robert Blank, Managing Consultant, as he moderates a panel with industry experts from Sanofi, Zydus, and UCB. Panel: “Process Improvement in Contract Administration and Management — Streamlining Chargeback Operations, GPO Rosters […]

EVERSANA Co-Sponsors Advanced Therapies & Regenerative Medicine Congress and Expo

We are excited to be a co-sponsor of the upcoming Advanced Therapies & Regenerative Medicine Congress & Expo. The conference will be held from May 15-17 in London, UK. Scott Clark, SVP for Global Strategic Alliances, will join a panel of esteemed industry thought leaders – from Cryoport, Mesoblast and UC Davis Health – in […]

EVERSANA Sponsors ISPOR New Orleans 2019

EVERSANA proudly announces our participation at ISPOR New Orleans as a Bronze Sponsor. ISPOR 2019, held May 18-22 in New Orleans, LA, is the leading global conference for Health Economics and Outcomes Research. This year’s conference theme: A New Era in HEOR connects the continual shift in the global healthcare landscape with essential developments in […]

How UK Payers view Biosimilar Hurdles

Over the last several years, market demand for biosimilars has accelerated particularly for high value reference products. Efforts have been undertaken to provide education, experience sharing platforms as well as coordinating tenders across regions in the UK. Given the success of these strategies in terms of market share penetration are there really any barriers which […]

EVERSANA Sponsors the 21st Annual CBI Medicaid and Government Pricing Congress

EVERSANA is a premier sponsor at the 21st Annual Medicaid and Government Pricing Congress on May 20-22, 2019, taking place in Orlando, Florida. Meet our team of experts who will be part of the discussion. Michael Kurland, VP, Revenue Management & Compliance Solutions Tuesday, May 21 at 4:45 pm Workshop G: Large Pharma (panelist) Joseph Birdsall, […]

EVERSANA Sponsors EYEFORPHARMA

EVERSANA is a key sponsor at EYEFORPHARMA, taking place April 16-17 in Philadelphia. Join our Kristin LaBounty Phillips from The Patient Experience Project, an EVERSANA agency, on Wednesday, April 17, at 9 am in the Pink Room as she moderates a panel of esteemed industry colleagues—from Pfizer, AstraZeneca, and Patient Power LLC.— in a discussion […]

EVERSANA – Gold Sponsor at Asembia 2019

EVERSANA is a proud gold sponsor of Asembia 2019 Specialty Pharmacy conference, taking place from April 29-May 2, 2019 in Las Vegas NV. Please join our team of experts for a conversation as we share our story on how we partner with pharmaceutical manufacturers to perform as an extension of their team and inform decisions […]

EVERSANA is a proud Gold Sponsor of The Patient Congress

ENSURE THE PATIENT IS AT THE CENTER OF YOUR STRATEGY EVERSANA was a proud sponsor of The Patient Congress, held this year in Philadelphia, PA. The two-day conference featured three tracks – Patient Adherence and Engagement, Patient Advocacy, and Rare Disease Market Access and Orphan Drug Commercialization – all focused on incorporating the patient voice […]

EVERSANA Sponsors the AMCP Annual Meeting

EVERSANA proudly sponsors The Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting. The annual meeting will be held March 25-28 at The San Diego Convention Center in San Diego, California. AMCP is dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health […]

EVERSANA Proudly Sponsors World Orphan Drug Congress

The Congress, held April 10-12 in Oxon Hill, MD, is the largest global annual gathering of orphan drug stakeholders focused on the evolving rare disease landscape. This year’s program has expanded to focus on cell and gene therapies for rare diseases as well as rare oncology, pricing and reimbursement, clinical development and regulatory, and advanced […]